GTR Home > Tests > Neuroblastoma -Sequence Analysis for ALK Ex 21-28 & PHOX2B Ex 1-3

Overview

Test name

Help

Neuroblastoma -Sequence Analysis for ALK Ex 21-28 & PHOX2B Ex 1-3

Purpose of the test

Help

This is a clinical test intended for Help: Diagnosis

Condition

Help

2 conditions tested. Click Indication tab for more information.

Methodology

Help
Molecular Genetics
ESequence analysis of select exons
Uni-directional Sanger sequencing
  • Applied Biosystems 3730 capillary sequencing instrument
CSequence analysis of the entire coding region
Uni-directional Sanger sequencing
  • Qiagen QIAcube

Summary of what is tested

2 genes and variants. Click Methodology tab for more information.

Genes

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

How to order

Help

Each specimen must be accompanied by a physician's test request. Informed consent is desirable. Proper billing information should also be provided on the test requisition form. Testing for PHOX2B mutations is not recommended for tumor samples. If a tumor sample is specimen type please order ALK testing only.

Test services

Help
  • Clinical Testing/Confirmation of Mutations Identified Previously

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.